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http://www.biomedcentral.com/1472-6874/14/17RESEARCH ARTICLE Open AccessReproductive factors, intima media thickness
and carotid plaques in a cross-sectional study of
postmenopausal women enrolled in the
population-based KORA F4 study
Doris Stöckl1,2*, Annette Peters1, Barbara Thorand1, Margit Heier1,3, Wolfgang Koenig4, Jochen Seissler5,
Joachim Thiery6, Wolfgang Rathmann7 and Christa Meisinger1,3Abstract
Background: Reproductive events may affect the onset of chronic diseases. We examined the possible association
between reproductive parameters and intima media thickness (IMT) or carotid plaques in the common carotid
artery in a population-based sample.
Methods: This cross-sectional study analysed data of 800 postmenopausal women aged 50 to 81 years of the
population-based KORA F4 study, conducted between 2006 and 2008 in Southern Germany. Reproductive
parameters were obtained by standardised interviews.
Results: Age at menarche below 12 years compared to 12-15 years was significantly associated with carotid
plaques (age-adjusted OR 2.23, 95% CI 1.13-4.43, p-value 0.018, multivariable adjusted 2.11, 1.05-4.26, 0.037), but
not with IMT. Ever use of hormone replacement therapy was inversely associated with carotid plaques (age-adjusted
0.60, 0.44-0.81, p = 0.001, multivariable-adjusted 0.62, 0.45-0.86, 0.003) and IMT in the age-adjusted model (mean 0.89,
95% CI 0.88-0.90, p = 0.033) but not in the multivariable-adjusted model (mean 0.89, 95% CI 0.88-0.90, p = 0.075). Parity,
age at menopause, time since menopause, duration of fertile period, current use of hormone replacement therapy, ever
use of oral contraceptives, hysterectomy, bilateral oophorectomy, hot flashes and depressive mood in relation to the
menopausal transition were not associated with carotid plaques or IMT.
Conclusion: Our study showed, that there may be an independent association between the reproductive parameters
age at menarche and ever use of hormone replacement therapy with carotid plaques in the common carotid artery,
but not with IMT. Further research, especially in studies with prospective population-based study design, is necessary
to assess in detail what events in women’s life lead to increased IMT or CP.
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The identification of risk factors or risk markers for pre-
vention of cardiovascular disease (CVD) represents an
important research area. Subclinical atherosclerosis, a
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reproduction in any medium, provided the orassessing intima media thickness (IMT) and the presence
of plaques (CP). The presence and progression of IMT
and CP are associated with the development of coronary
artery disease events to some extend [1-4]. Yet, a recently
published meta-analysis found CP to be more accurate
than IMT in predicting these events [5].
CVD affects women nearly as often as men. In earlier
adulthood, women are more protected, but after meno-
pause the sex difference diminishes [6], suggesting an
effect of female hormones with possible protection of
the premenopausal hormonal status. So far, there is atd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Reproductive events during the life-span of women
have been shown to be associated with chronic diseases.
Lower age at menarche is associated with diabetes [7],
CVD [8], metabolic syndrome [9] and mortality [8]. Par-
ity was shown to be associated with CVD [10] and the
metabolic syndrome [11,12]. The menopausal transition
is associated with CVD [13] and hormone replacement
therapy (HRT) in form of estrogen and progesterone
application increases the risk of CVD [14]. But HRT has
been reported to have an initially protective effect on the
calcification of the coronary arteries [15].
There are only a few prior studies on whether repro-
ductive factors are associated with IMT or CP, which are
markers for early atherosclerosis and appear before the
onset of symptomatic CVD. A population-based study of
746 Finish women aged 45-74 showed that of all exam-
ined reproductive factors, only stillbirth was associated
with an increased risk of atherosclerotic plaques [16].
This study has examined various reproductive factors,
but for example age at menarche was not examined.
Other studies have only examined selected reproductive
factors and their association with IMT and so far there
are only few population-based studies. Oophorectomy
before natural menopause [17] and hot flashes, as a sign
of the vasomotor symptoms during menopausal transi-
tion have been found to be associated with an increased
IMT [18,19], but other studies don’t support this associ-
ation [20]. Parity has been related to increased IMT [21]
in younger [22] as well as in elderly women [23].
The aim of this study is to investigate whether there is
an association between a variety of reproductive parame-
ters and IMTand CP in the common carotid artery (CCA)
in postmenopausal women from the general population.
Methods
Subjects
The KORA F4 (2006-2008) study is the 7-year follow-up
study of the KORA S4 (1999-2001) study, a population-
based health survey performed in the city of Augsburg
and their two surrounding counties in Southern Germany.
The abbreviation KORA stands for Cooperative Health
Research in the Region of Augsburg. The target popula-
tion for the S4 baseline study consists of all German
residents of the region aged 25 to 74 years. Of the ran-
domly selected 6640 subjects, 4261 (64.2%) participated
in the S4 baseline study. The study design, sampling
method and data collection have been described in
detail elsewhere [24].
Of the 4261 participants in S4, 3080 took part in the
F4 follow-up study. Participants were not invited for F4
if they were deceased (n = 176, 4%), relocated outside the
study region, were lost to follow-up (n = 206, 5%) or haddemanded deletion of their address data (n = 12, 0.2%). Of
the remaining 3867 eligible persons, the contact failed for
174, 218 were not able to participate in the study because
they were too ill or had no time, and 395 denied participa-
tion in the follow-up. The final response rate was 79.6%.
For the current analysis all postmenopausal women aged
50 to 81 years at follow-up (n = 940) were included.
From this sample, we excluded 140 females for whom
no or incomplete information on CP, carotid IMT or any
of the covariables was available. Therefore, this analysis fi-
nally included 800 study participants. These 140 excluded
women did not differ significantly regarding age, BMI and
other main charactersistcs from the included 800 women.
The investigations were carried out in accordance with
the Declaration of Helsinki, including written informed con-
sent of all study participants. The study was approved by the
Ethics Committee of the Bavarian Medical Association.
Data collection
Information on sociodemographic variables, smoking habits,
physical activity level, medication use, reproductive parame-
ters and alcohol consumption were gathered by trained
medical staff during a standardized interview. Education
was estimated by recording years of schooling completed.
In addition, all study participants underwent a standardized
medical examination. All measurement procedures have
been described in detail elsewhere [24]. Anthropometric
measurements were performed after subjects had removed
their shoes, heavy clothing and belts. Body height was
measured to the nearest 0.1 cm and weight to the nearest
0.1 kg. BMI was calculated as weight [kg] divided by
height2 [m2]. Waist circumference (WC) was measured at
the level midway between the lower rib margin and the
iliac crest. Actual hypertension was defined as blood
pressure values greater than 140/90 mmHg or the use of
antihypertensive medication, given that the subjects were
aware of being hypertensive. Individuals who participated
in leisure time physical activity during summer and winter
and were active for at least one hour per week in either
season were classified as being physically active. Women
who consumed more than 20 g alcohol per day were
regarded as heavy alcohol drinkers. A fasting venous blood
sample was obtained from all study participants while
sitting. The parameters total cholesterol, triglycerides and
fasting blood glucose were used for the analysis. Fasting
blood glucose was analyzed using a hexokinase method
(GLU Flex of Dade Behring, Germany), fasting triglycerides
(TG) with the TGL Flex GPO-PAP assay of Dade Behring
and the analysis of total cholesterol wase carried out using
the analyzer Dimension RxL (Dade Behring, Germany).
Assessment of reproductive parameters
Reproductive parameters were obtained through personal
interviews by trained medical staff in the KORA S4 and
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variables were obtained in both interviews and underwent
rigorous quality assessment for internal validity. For this
analysis mainly data of the KORA F4 study were used.
Women were classified postmenopausal at the absence
of menstrual bleeding for 12 consecutive months, if they
had bilateral oophorectomy (either alone or in combination
with hysterectomy) and had hysterectomy without bilateral
oophorectomy and were above 50 years (without reported
menopause before hysterectomy). This was asked in the S4
and F4 interview. Age at menarche was defined as age at
the first menstrual bleeding, assessed in full years. The
question, which was asked only in the baseline S4 study
was open-ended: “At what age did you have your first
menstrual period (menarche)?” Women were asked in
S4 and F4 to recall their number of pregnancies and
live-born children, if they ever used oral contraceptives
or HRT. Parity was defined as the number of reported
deliveries. At the examination date in the F4 study, all
subjects were asked to bring their current medication
to the study center and the barcode of each medication
was scanned. From these data the category current use of
HRT was constructed. There was no further differentiation
in the type of HRT, e.g. with or without progestin use.
Ever use of oral contraception or HRT was assessed in
the interviews. Furthermore the women were asked about
the presence of two symptoms of the menopausal transi-
tion: hot flashes and depressive mood. Age at menopause
was inquired in both surveys and is only available for
602 women. The high amount of missing values is due to
the difficult assessment of this variable, because ongoing
vaginal bleeding due to HRT and hysterectomy early in life
without bilateral oophorectomy while still being premeno-
pausal, make an age determination challenging and some
women simply don’t remember their age at menopause.
From the variable age at menopause the variables time
since menopause (current age minus age at menopause) in
years and fertility duration (age at menopause minus age
at menarche) in years are constructed.Vascular examination
Ultrasound measurement of IMT was performed as de-
scribed previously [26]. Briefly, CCAs were scanned in
angles of 60°-180° (right CCA) and 210°-300° (left
CCA) using a high resolution ultrasound system (Sono-
line G50, Siemens Medical Solutions, Munich, Germany
or Acuson X300, Siemens Medical Solutions, Munich,
Germany). Optimal images of the far wall were recorded
on DVD videotapes. Measurements of IMT were per-
formed off-line over a length of 10 mm beginning at
0-5 mm of the dilatation of the distal CCA using an
automated edge detection reading system (Prowin soft-
ware, Medical Technologies International, USA) by onecertified reader. The mean of the left and right CCA were
used to calculate IMT.
Plaques were defined as a distinct area with either
rising into the lumen or mineralization. CP assessment
was performed from the DVD videotapes which were
recorded for the IMT measurement. Therefore only pla-
ques in the CCA were assessed. No further vessels were
scanned for plaques.
Statistical analyses
Basic characteristics of the study population were ana-
lyzed for the whole sample and stratified for carotid
plaques. For normally distributed variables the mean and
standard deviation and for categorical variables percentages
were calculated. Two models were fitted, the first one
controlling for age, the second model uses a multivariable
approach with age, BMI, education, family status, physical
activity, smoking, alcohol consumption, fasting blood
glucose levels, total cholesterol and triglycerides as po-
tential confounder. For the selection of confounder a
literature research was performed, which showed that
age, BMI, social status (education and family status
were considered in our study to represent social status),
physical activity, alcohol consumption and smoking
were included as confounder in comparable studies
[1,16,27]. Generalized linear models were used for the
analysis of IMT and logistic regression analyses for CP.
Significance tests were two-tailed and p-values less than
0.05 were considered statistically significant. All analyses
were performed using SAS (version 9.3, SAS Institute Inc,
Cary, NC, USA).
Results
This study comprises 800 postmenopausal women aged
50 to 81 years. Basic characteristics of the whole study
sample and according to the presence or absence of CP
in the CCA are presented in Table 1. Women with CP
were older and more likely to suffer from hypertension
or diabetes. They were less likely to be heavy alcohol
drinkers and were less physically active. Women without
CP were more likely to have a history of oral contraceptive
or HRT use.
The mean IMT of all women included in this analysis
was 0.895 mm with a standard deviation of 0.124. Table 2
presents the associations between the examined repro-
ductive parameters and IMT. Ever use of HRT, but not
current use, was associated with IMT in the age-adjusted
model (mean 0.89, 95% CI 0.88-0.90, p-value 0.033). After
further adjustment for additional risk factors statistical
significance was lost. There was no significant interaction
between current use of HT and time since menopause
(p-value 0.711). Parity, age at menopause, time since meno-
pause, duration of fertile period, current use of hormone
replacement therapy, ever use of oral contraceptives,
Table 1 Selected characteristics of the study population for the whole sample and stratified for carotid plaques in the
common carotid artery
Whole study population No plaque Plaque p-values
n 800 498 302
Age (years) 64.2 (8.2) 62.0 (7.6) 67.9 (8.0) <0.0001
IMT (mm) 0.895 (0.124) 0.856 (0.109) 0.961 (0.119) <0.0001
Waist circumference (cm) 91.4 (12.5) 90.7 (12.9) 92.5 (11.8) 0.051
BMI (kg/m2) 28.4 (5.1) 28.2 (5.2) 28.7 (4.9) 0.143
BMI at age 25 years (kg/m2) 22.5 (3.3) 22.4 (3.4) 22.7 (3.2) 0.300
Family status (%) 0.075
Single 5.3 4.8 6.5
Married 66.8 69.4 61.6
Divorced or widowed 28.0 25.8 32.0
Education < 10 years (%) 62.3 57.2 70.1 0.0003
Systolic BP (mmHg) 121.6 (18.1) 120.6 (16.6) 125.0 (19.8) 0.001
Diastolic BP (mmHg) 73.6 (9.2) 74.5 (8.8) 72.5 (9.7) 0.003
History of diabetes (%)1 13.2 11.2 16.7 0.029
Actual hypertension (%)2 44.8 40.7 55.8 <0.0001
Current use of antihypertensive medication (%) 41.1 33.5 53.7 <0.0001
Total cholesterol (mg/dl) 230.6 (38.5) 62.6 (14.6) 61.0 (14.8) 0.951
Fasting glucose (mg/dl) 98.7 (17.3) 97.5 (15.3) 100.8 (20.0) 0.010
Triglycerides (mg/dl) 121.3 (73.9) 119.0 (77.4) 125.2 (66.8) 0.251
Alcohol > 20 g/day (%) 16.0 16.1 15.0 0.079
Current smoking (%) 10.9 11.2 10.9 0.844
Physically active (%) 56.0 60.1 48.0 0.001
Menarche (years) 13.6 (1.7) 13.6 (1.6) 13.8 (1.8) 0.104
Parity (%) 0.195
0 11.8 10.3 14.6
1-2 48.1 49.8 44.9
>2 40.2 39.9 40.5
Age at menopause (years)3 49.0 (5.0) 48.7 (5.1) 49.3 (4.8) 0.143
Time since menopause (years)3 15.8 (9.0) 13.8 (8.6) 18.9 (8.7) <0.0001
Duration of Fertility (years)3 35.3 (5.1) 35.1 (5.2) 35.5 (5.0) 0.322
Current HRT (%) 14.4 16.9 10.5 0.010
Ever HRT (%) 59.0 64.0 50.3 <0.0001
Ever OC (%) 61.6 66.7 54.8 0.0005
Hysterectomy (%) 33.8 34.7 32.0 0.286
Bilateral oophorectomy (%) 6.8 7.0 6.5 0.687
Hot flashes (%) 43.2 48.3 34.7 <0.0001
Depressive mood (%) 37.1 35.7 37.8 0.695
Data presented as mean (standard deviation) or percentage respectively.
Abbreviations: BMI: Body Mass Index, BP: Blood pressure, HRT: Hormone replacement therapy, OC: oral contraceptives.
p-values are presented for the difference of present and absent plaques.
1 missing information for 13 women.
2 actual hypertension was defined as current use of blood pressure lowering medication or a blood pressure ≥140/90 mmHg, given that the subjects were aware
of being hypertensive.
3 n = 602, due to missing values of age at menopause.
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Table 2 Intima media thickness (mm) and reproductive parameters in 800 postmenopausal women from the
KORA F4 study
Age-adjusted Multivariable-adjusted
Mean 95% CI p-value Mean 95% CI p-value
Menarche 0.701 0.873
<12 years 0.906 0.879-0.933 0.902 0.875-0.929
12-15 years 0.895 0.886-0.903 0.894 0.886-0.903
>15 years 0.892 0.872-0.914 0.896 0.875-0.917
Parity 0.114 0.407
0 0.876 0.854-0.898 0.883 0.860-0.905
1-2 0.895 0.884-0.906 0.895 0.884-0.906
>2 0.902 0.890-0.914 0.900 0.888-0.912
Age at menopause1 0.766 0.590
≥ 50 years 0.903 0.890-0.915 0.904 0.891-0.916
< 50 years 0.900 0.887-0.913 0.899 0.886-0.912
Time since menopause1 0.136 0.079
> 15 years 0.891 0.875-0.907 0.889 0.873-0.905
≤ 15 years 0.911 0.895-0.928 0.913 0.897-0.929
Duration of fertility1 0.645 0.683
> 35.0 0.903 0.891-0.913 0.903 0.891-0.915
≤ 35.0 0.899 0.886-0.909 0.899 0.886-0.912
Current use of HRT 0.817 0.711
Yes 0.893 0.873-0.913 0.899 0.879-0.919
No 0.896 0.887-0.904 0.895 0.887-0.903
Ever use of HRT 0.033 0.075
Yes 0.888 0.878-0.898 0.890 0.880-0.900
No 0.905 0.893-0.917 0.902 0.891-0.914
Ever use of OC 0.767 0.394
Yes 0.896 0.886-0.906 0.898 0.888-0.908
No 0.894 0.880-0.907 0.891 0.878-0.904
Hysterectomy 0.370 0.277
Yes 0.890 0.877-0.903 0.888 0.875-0.901
No 0.898 0.888-0.907 0.899 0.890-0.908
Bilateral oophorectomy 0.775 0.614
Yes 0.891 0.862-0.920 0.888 0.859-0.917
No 0.896 0.888-0.903 0.896 0.888-0.904
Hot flashes 0.684 0.452
Yes 0.893 0.881-0.905 0.892 0.880-0.904
No 0.897 0.886-0.907 0.898 0.888-0.908
Depressive mood 0.753 0.989
Yes 0.897 0.884-0.909 0.895 0.883-0.906
No 0.894 0.885-0.904 0.895 0.886-0.905
Abbreviations: HRT: Hormone replacement therapy, OC: oral contraceptives.
Generalized linear models.
Estimated means of IMT are presented.
Multivariable-adjusted: Age, BMI, education, family status, physical activity, smoking, alcohol consumption, total cholesterol, triglycerides and fasting
blood glucose.
1n = 602, due to missing values of age at menopause.
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depressive mood in relation to the menopausal transi-
tion were not associated with IMT.
Table 3 displays the association between the reproduct-
ive parameters and CP in the CCA, assessed by logistic
regression analysis. Ever use of HRT, but not current
use, was significantly inversely associated with CP (age-
adjusted: OR 0.60, 95% CI 0.44-0.81, and multivariable-
adjusted: OR 0.62, 95% CI 0.45-0.86) and lower age at
menarche was associated with CP (below 12 years,
compared to 12-15years) (age-adjusted: OR 2.23, 95%
CI 1.13-4.43, multivariable-adjusted: OR 2.11, 95% CI
1.05-4.26). All other examined reproductive parameters
showed no significant association with CP.
Discussion
The present cross-sectional study shows that only a few
reproductive parameters are associated with IMT and CP
in the CCA, both early markers of atherosclerosis. There
was an age-adjusted association of ever use of HRT with
decreased IMT and reduced presence of CP, however,
statistical significance remained only for CP after multi-
variable adjustment. An age at menarche below 12 years
was associated with increased presence of CP, but not
IMT. All other examined reproductive factors did not
show an association, neither with CP nor IMT.
The findings in this study support the results from other
studies in which early age at menarche has been shown to
be associated with premature CVD [8], cardiovascular risk
factors like metabolic syndrome [9], diabetes [7] as well
as peripheral arterial disease (PAD) [28]. The underlying
reasons for these associations are not completely under-
stood. Earlier onset of menarche could be due to obesity
in childhood. It has been shown that obese children who
stayed obese in adolescence and young adulthood had an
increased risk of carotid-artery atherosclerosis, as well as
hypertension, dyslipidemia and type 2 diabetes. This effect
could not be shown in obese children who were normal
weight in adulthood. Their risk was comparable to never
obese individuals [29]. Thus, it might be assumed that
obesity has an effect on the association between early age
at menarche and early signs of atherosclerosis, such as
IMT or CP. However, in the present study, earlier age
at menarche was independently of BMI associated with
the presence of CP. This finding needs to be confirmed
or refuted in further large, particularly prospective
population-based studies. Another pathway for the as-
sociation of age at menarche with CP might be due to
genetic traits. Recent genome-wide association studies
showed obesity loci to be associated with age at menarche,
suggesting complex genetic interrelationships [30].
In the present study ever use of HRT was associated with
a lower risk of CP in the CCA, even after multivariable
adjustment, while current use of HRT was not associatedwith CP. A cross-sectional study in 538 postmenopausal
women in France, Belgium and the Netherlands showed
that ever users of HRT had smaller and thinner carotid
artery walls than nonusers with a lower rate of progression
of subclinical atherosclerosis [31]. These findings are in
partial contrast to findings from large observational
studies like the Nurses’ Health study or the randomized
double-blinded Women’s Health Initiative (WHI) [14,15].
Differences between observational studies and randomized
trials have been argued to be due to the selection of
women. It is known that women who chose to take
HRT compared to women who did not, differ in certain
characteristics like education, social status, and the
prevalence of chronic diseases in observational epide-
miologic studies [31]. The WHI showed that users of
HRT have less calcification than nonusers, but they state
that estrogen has complex biologic effects and may influ-
ence the risk for cardiovascular events and other out-
comes through multiple pathways [15]. Recently published
results show that there was no decreased risk of CHD
in subgroups of women, e.g. who started HRT within
10 years after menopause. But subgroups were small
[14]. We tried to adjust for all possible confounders,
but residual confounding cannot be entirely excluded.
Therefore our finding of an association between ever
use of HRT and CP needs to be interpreted carefully.
Hot flashes during the menopausal transition have been
associated with increased IMT in some studies [18,19],
but other studies did not see this association [20,32].
The reasons for these conflicting results may be due to
different study designs (e.g. assessment of hot flashes,
inclusion and exclusion criteria) and differences in the
study sample (e.g. age, position in the menopausal tran-
sition, cardiovascular risk factors). The association of
hot flashes with CP has to our knowledge not been
described before.
Premenopausal hormonal influence is expected to be
protective of CVD. In early adulthood women are more
protected than men, but after menopause this sex differ-
ence diminishes. Reproductive factors which occur over
the life span of women do influence plasma levels of female
hormones. This effect is well observed during pregnancy.
Compared to non-pregnant women there are marked
differences in the hormone levels with metabolic and
functional changes. Cardiovascular regulations have been
shown to change early in pregnancy, persist postpartum
and seem to be enhanced during subsequent pregnancy
[33]. The authors speculated that the changes during
pregnancy might lower cardiovascular risk in later life.
The findings in this study, where no associations between
parity, and duration of fertility and IMT were found, are
in contrast to other studies [21-23]. Wolff et al showed in
another German population-based study (SHIP study)
that nulliparity and a higher number of children were
Table 3 Carotid plaques in the common carotid artery and reproductive parameters in 800 postmenopausal women,
the KORA F4 study
Age-adjusted Multivariable-adjusted
OR 95% CI p-value OR 95% CI p-value
Menarche
<12 years 2.23 1.13-4.43 0.018 2.11 1.05-4.26 0.037
12-15 years**
>15 years 1.22 0.77-1.92 0.290 1.25 0.79-1.99 0.436
Parity
0 1.37 0.83-2.26 0.195 1.41 0.83-2.38 0.186
1-2 1.01 0.73-1.41 0.397 1.02 0.73-1.42 0.383
>2**
Age at menopause1
≥ 50 years 0.94 0.66-1.33 0.714 1.00 0.70-1.45 0.962
< 50 years**
Time since menopause1
> 15 years 0.97 0.58-1.63 0.921 0.91 0.54-1.53 0.772
≤ 15 years**
Duration of fertility1
> 35.0 years 0.84 0.59-1.20 0.339 0.87 0.61-1.25 0.449
≤ 35.0 years**
Current use of HRT
Yes 0.78 0.49-1.24 0.294 0.79 0.49-1.26 0.316
No**
Ever use of HRT
Yes 0.60 0.44-0.81 0.001 0.62 0.45-0.86 0.003
No**
Ever use of OC
Yes 1.25 0.89-1.78 0.203 1.34 0.93-1.90 0.125
No**
Hysterectomy
Yes 0.84 0.61-1.16 0.285 0.83 0.60-1.16 0.284
No**
Bilateral oophorectomy
Yes 0.68 0.37-1.26 0.221 0.65 0.35-1.22 0.178
No**
Hot flashes
Yes 0.93 0.67-1.30 0.664 0.90 0.64-1.26 0.535
No**
Depressed mood
Yes 1.16 0.84-1.60 0.367 1.15 0.83-1.59 0.396
No**
Logistic regression analyses.
Abbreviations: HRT: Hormone replacement therapy, OC: oral contraceptives
**reference group.
Multivariable-adjusted: Age, BMI, education, family status, physical activity, smoking, alcohol consumption, total cholesterol, triglycerides and fasting
blood glucose.
1n = 602, due to missing values of age at menopause.
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this association was partially mediated through conven-
tional risk factors and socioeconomic determinants.
Genome-wide association studies have recently found
no evidence that SNP´s associated with coronary artery
disease are associated with carotid IMT and therefore
suggested that genetic associations are not acting via early
vessel remodeling or early atherosclerosis [34].
IMT is a less reliable marker for early atherosclerosis
than CP. IMT measurements are widely used in clinical
practice to assess early atherosclerosis due to its non-
invasive technique. But IMT without presence of CP
represents mainly hypertensive medial hypertrophy and
has a lower sensitivity to predict cardiovascular events
[5]. A recent meta-analysis has shown that CP, compared
with carotid IMT, more accurately predicts coronary
artery disease events, like myocardial infarction [5].
The study showed that the absence of CP provides
greater assurance with 10-year myocardial infarction
event rates of 4.0% (95% CI 3.6–4.7%) [5].
The advantage of our study is the population-based
design. The study sample was drawn randomly from the
general population. Another strength is the collection
of the data by experienced examiners according to
standardized protocols. The sonographers did not know
about the cardiovascular history of the subjects and
measurements underwent rigorous quality control. Mul-
tiple reproductive factors have been assessed. Furthermore
this study uses mean IMT values, which are better reprodu-
cible and less susceptible to outliers compared to maximal
carotid IMT measurements which reflect more advanced
stages with focal thickening [5]. Limitations are the cross-
sectional design; therefore cause and effect relationships
cannot be stated. Screening for CP was only performed in
the CCA during the measurement of IMT. This is a severe
limitation for the results of our study, because no further
vessels were screened for the prevalence of plaques, a
procedure which has been recommended by Inaba
et. al.: Carotid IMT assessment should always be supple-
mented by a thorough scan of the extra cranial carotid ar-
teries for CP assessment to increase the diagnostic
performance of carotid ultrasound [5]. Nevertheless we
think that the results of our study are interesting and
worth to be presented despite the lack of systematic
plaque assessment because there are very few studies
published who examined the association of reproductive
parameters and CP. Another limitation of the study is that
information on CVD events was not yet available for
the analysis. Furthermore, some reproductive variables
were categorized rather broad, like hot flashes. In the
KORA F4 study the women were only asked if they
currently suffer from hot flashes, without asking for the
duration or severity. The same applies to current use or
past use of HRT. The categories were yes/no withoutdifferentiation on application forms, dosages and formulas.
A recall bias cannot be ruled out due to the assessment of
reproductive variables in the interview.
Conclusion
Our study showed a significantly positive association of
early menarche with CP in the common carotid artery and
a significant inverse association of ever use of hormone
replacement therapy and CP. There was no independent
association between any of the investigated reproductive
parameters and IMT. The findings of this study are
explorative and possibly due to chance and need to be
proven in further population-based studies with a bigger
sample size. Further research, especially in studies with
prospective population-based study designs, is necessary
to assess in detail what events in women’s life lead to
increased IMT or CP.
Abbreviations
BMI: Body mass index; BP: Blood pressure; CCA: Common carotid artery;
CP: Carotid plaques; CVD: Cardiovascular disease; HRT: Hormone replacement
therapy; IMT: Intima media thickness; OC: Oral contraceptives.
Competing interest
The authors declare that they have no competing interest.
Authors’ contribution
DS planned the study, performed the data analysis and wrote the
manuscript. CM contributed to the acquisition of data, planning of the study,
the performance of the data analysis and reviewed and edited the
manuscript. BT, AP, JT, WK, JS, WR and MH contributed to the acquisition of
data and reviewed and edited the manuscript. All authors have viewed and
approved the final version of the manuscript.
Acknowledgement
The KORA research platform (KORA, Cooperative Research in the Region of
Augsburg) was initiated and financed by the Helmholtz Zentrum München,
German Research Center for Environmental Health (GmbH), which is funded
by the German Federal Ministry of Education, Science, Research and
Technology and by the State of Bavaria. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of
the manuscript. We thank all the study participants, all members of staff of
the Institute of Epidemiology II and the field staff in Augsburg who planned
and conducted the study.
Measurement of IMT was funded by a grant of the Karl-Wilder-Foundation (JS).
Author details
1Institute of Epidemiology II, Helmholtz Zentrum München, German
Research Center for Environmental Health, Neuherberg, Germany.
2Department of Obstetrics and Gynaecology, Campus Grosshadern,
Ludwig-Maximilians-University, Munich, Germany. 3Central Hospital of
Augsburg, MONICA/KORA Myocardial Infarction Registry, Augsburg, Germany.
4Department of Internal Medicine II – Cardiology, University of Ulm Medical
Center, Ulm, Germany. 5Medizinische Klinik und Poliklinik IV, Diabetes Zentrum -
Campus Innenstadt, Klinikum der Ludwig-Maximilians-Universität, München and
Clinical Cooperation Group Diabetes, Ludwig-Maximilians-Universität München
and Helmholtz Zentrum München, Munich, Germany. 6Institute of Laboratory
Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig,
Leipzig, Germany. 7Institute of Biometrics and Epidemiology, German Diabetes
Center, Leibniz Center for Diabetes Research at Heinrich Heine University,
Düsseldorf, Germany.
Received: 12 August 2013 Accepted: 18 January 2014
Published: 24 January 2014
Stöckl et al. BMC Women's Health 2014, 14:17 Page 9 of 9
http://www.biomedcentral.com/1472-6874/14/17References
1. Lamina C, Meisinger C, Heid IM, Lowel H, Rantner B, Koenig W, Kronenberg F:
Association of ankle-brachial index and plaques in the carotid and femoral
arteries with cardiovascular events and total mortality in a population-
based study with 13 years of follow-up. Eur Heart J 2006, 27:2580–2587.
2. Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Volzke H, Tuomainen TP,
Sander D, Plichart M, Catapano AL, Robertson CM, et al: Carotid
intima-media thickness progression to predict cardiovascular events in the
general population (the PROG-IMT collaborative project): a meta-analysis of
individual participant data. Lancet 2012, 379:2053–2062.
3. Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, Zavodni AE, O'Leary DH:
The value of carotid artery plaque and intima-media thickness for incident
cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart
Assoc 2013, 2:e000087.
4. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr:
Carotid-wall intima-media thickness and cardiovascular events. N Engl J
Med 2011, 365:213–221.
5. Inaba Y, Chen JA, Bergmann SR: Carotid plaque, compared with carotid
intima-media thickness, more accurately predicts coronary artery disease
events: a meta-analysis. Atherosclerosis 2012, 220:128–133.
6. Gerhard M, Baum P, Raby KE: Peripheral arterial-vascular disease in women:
prevalence, prognosis, and treatment. Cardiology 1995, 86:349–355.
7. Stöckl D, Döring A, Peters A, Thorand B, Heier M, Huth C, Stöckl H,
Rathmann W, Kowall B, Meisinger C: Age at menarche is associated with
prediabetes and diabetes in women (aged 32-81 years) from the general
population: the KORA F4 Study. Diabetologia 2012, 55:681–688.
8. Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, Wareham NJ,
Ong KK: Early age at menarche associated with cardiovascular disease and
mortality. J Clin Endocrinol Metab 2009, 94:4953–4960.
9. Stöckl D, Meisinger C, Peters A, Thorand B, Huth C, Heier M, Rathmann W,
Kowall B, Stöckl H, Döring A: Age at menarche and its association with
the metabolic syndrome and its components: results from the KORA F4
study. PLoS One 2011, 6:e26076.
10. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF,
Ingelsson E: Parity and risk of later-life maternal cardiovascular disease.
Am Heart J 2010, 159:215–221. e216.
11. Cohen A, Pieper CF, Brown AJ, Bastian LA: Number of children and risk
of metabolic syndrome in women. J Womens Health (Larchmt) 2006,
15:763–773.
12. Gunderson EP, Jacobs DR Jr, Chiang V, Lewis CE, Tsai A, Quesenberry CP Jr,
Sidney S: Childbearing is associated with higher incidence of the
metabolic syndrome among women of reproductive age controlling for
measurements before pregnancy: the CARDIA study. Am J Obstet Gynecol
2009, 201:177. e171-179.
13. Kannel WB, Hjortland MC, McNamara PM, Gordon T: Menopause and risk
of cardiovascular disease: the Framingham study. Ann Intern Med 1976,
85(4):447–52.
14. Toh S, Hernandez-Diaz S, Logan R, Rossouw JE, Hernan MA: Coronary heart
disease in postmenopausal recipients of estrogen plus progestin therapy:
does the increased risk ever disappear? A randomized trial. Ann Intern Med
2010, 152:211–217.
15. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH,
Cochrane BB, Hunt JR, Ludlam SE, et al: Estrogen therapy and
coronary-artery calcification. N Engl J Med 2007, 356:2591–2602.
16. Kharazmi E, Moilanen L, Fallah M, Kaaja R, Kattainen A, Kahonen M, Jula A,
Kesaniemi A, Luoto R: Reproductive history and carotid intima-media
thickness. Acta Obstet Gynecol Scand 2007, 86:995–1002.
17. Ozkaya E, Cakir E, Okuyan E, Cakir C, Ustun G, Kucukozkan T: Comparison of
the effects of surgical and natural menopause on carotid intima media
thickness, osteoporosis, and homocysteine levels. Menopause 2011,
18:73–76.
18. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Powell LH,
Matthews KA: Hot flashes and carotid intima media thickness among
midlife women. Menopause 2011, 18:352–358.
19. Ozkaya E, Cakir E, Kara F, Okuyan E, Cakir C, Ustun G, Kucukozkan T: Impact
of hot flashes and night sweats on carotid intima-media thickness and
bone mineral density among postmenopausal women. Int J Gynaecol
Obstet 2011, 113:235–238.
20. Bechlioulis A, Kalantaridou SN, Naka KK, Chatzikyriakidou A, Calis KA,
Makrigiannakis A, Papanikolaou O, Kaponis A, Katsouras C, Georgiou I, et al:
Endothelial function, but not carotid intima-media thickness, is affectedearly in menopause and is associated with severity of hot flushes. J Clin
Endocrinol Metab 2010, 95:1199–1206.
21. Wolff B, Volzke H, Robinson D, Schwahn C, Ludemann J, Kessler C, John U,
Felix SB: Relation of parity with common carotid intima-media thickness
among women of the study of health in Pomerania. Stroke 2005,
36:938–943.
22. Skilton MR, Bonnet F, Begg LM, Juonala M, Kahonen M, Lehtimaki T, Viikari JS,
Raitakari OT: Childbearing, child-rearing, cardiovascular risk factors, and
progression of carotid intima-media thickness: the Cardiovascular Risk in
Young Finns study. Stroke 2010, 41:1332–1337.
23. Humphries KH, Westendorp IC, Bots ML, Spinelli JJ, Carere RG, Hofman A,
Witteman JC: Parity and carotid artery atherosclerosis in elderly women:
the Rotterdam study. Stroke 2001, 32:2259–2264.
24. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H: Sex
differences in risk factors for incident type 2 diabetes mellitus: the
MONICA Augsburg cohort study. Arch Intern Med 2002, 162:82–89.
25. Stöckl D, Döring A, Thorand B, Heier M, Peters A, Lamina C, Kronenberg F,
Meisinger C: Reproductive factors and its association with peripheral
arterial disease in women aged 52-81 years: the KORA F4 study.
Atherosclerosis 2013, 228:224–229.
26. Kowall B, Ebert N, Then C, Thiery J, Koenig W, Meisinger C, Rathmann W,
Seissler J: Associations between blood glucose and carotid intima-media
thickness disappear after adjustment for shared risk factors: the KORA
F4 study. PLoS One 2012, 7:e52590.
27. Yeh ST, Morton DJ, Barrett-Connor E: Lower extremity arterial disease in
older women: the Rancho Bernardo study. J Womens Health Gend Based
Med 2000, 9:373–380.
28. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR,
Karas RH, Lovell MB, McDermott MM, et al: A call to action: women and
peripheral artery disease: a scientific statement from the American Heart
Association. Circulation 2012, 125:1449–1472.
29. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA,
Srinivasan SR, Daniels SR, Davis PH, Chen W, et al: Childhood adiposity,
adult adiposity, and cardiovascular risk factors. N Engl J Med 2011,
365:1876–1885.
30. Fernandez-Rhodes L, Demerath EW, Cousminer DL, Tao R, Dreyfus JG, Esko T,
Smith AV, Gudnason V, Harris TB, Launer L, et al: Association of adiposity
genetic variants with menarche timing in 92,105 women of European
descent. Am J Epidemiol 2013, 178:451–460.
31. Gompel A, Boutouyrie P, Joannides R, Christin-Maitre S, Kearny-Schwartz A,
Kunz K, Laurent S, Boivin JM, Pannier B, Pornel B, et al: Association of
menopause and hormone replacement therapy with large artery
remodeling. Fertil Steril 2011, 96:1445–1450.
32. Wolff EF, He Y, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA,
Manson JE, Merriam GR, et al: Self-reported menopausal symptoms, coronary
artery calcification, and carotid intima-media thickness in recently
menopausal women screened for the Kronos early estrogen prevention
study (KEEPS). Fertil Steril 2013, 99:1385–1391.
33. Clapp JF 3rd, Capeless E: Cardiovascular function before, during, and after
the first and subsequent pregnancies. Am J Cardiol 1997, 80:1469–1473.
34. Conde L, Bevan S, Sitzer M, Klopp N, Illig T, Thiery J, Seissler J, Baumert J,
Raitakari O, Kahonen M, et al: Novel associations for coronary artery
disease derived from genome wide association studies are not
associated with increased carotid intima-media thickness, suggesting
they do not act via early atherosclerosis or vessel remodeling.
Atherosclerosis 2011, 219:684–689.
doi:10.1186/1472-6874-14-17
Cite this article as: Stöckl et al.: Reproductive factors, intima media
thickness and carotid plaques in a cross-sectional study of postmeno-
pausal women enrolled in the population-based KORA F4 study. BMC
Women's Health 2014 14:17.
